
Curiscent Pharma Private Limited
Founded in 2024 and headquartered in Madhya Pradesh, India.
Founded in 2024 and headquartered in Madhya Pradesh, India.
Curiscent Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 January 2024 (One year and two months 3 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Singh and Abhinav Thakur serve as directors at the Company.
Bhopal, Madhya Pradesh, India
+91-XXXXXXXXXX
-
U46497MP2024PTC069219
069219
Private Limited Indian Non-Government Company
02 Jan 2024
-
-
Unlisted
Roc Gwalior
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Singh ![]() | Director | 02-Jan-2024 | Current |
Abhinav Thakur ![]() | Director | 02-Jan-2024 | Current |
Enhance accessibility to Curiscent Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Curiscent Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Sunil Singh is a mutual person
Abhinav Thakur is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Curiscent Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curiscent Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curiscent Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sunil Singh was appointed as a Director was appointed as a Director on 02 Jan 2024 & has been associated with this company since 1 year 2 months .
Abhinav Thakur was appointed as a Director was appointed as a Director on 02 Jan 2024 & has been associated with this company since 1 year 2 months .
Curiscent Pharma Private Limited was registered on 02 Jan 2024 with Roc Gwalior & aged 1 year 2 months as per MCA records.
Curiscent Pharma Private Limited was incorporated on 02 Jan 2024.
The authorized share capital of Curiscent Pharma Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Curiscent Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Curiscent Pharma Private Limited is H.No A 14 Asnani Santafe Ph-1 Village Katara, India, Huzur, Madhya Pradesh, 462043.
The corporate identification number (CIN) of Curiscent Pharma Private Limited is U46497MP2024PTC069219 and the company number is 069219 as per Ministry of Corporate Affairs (MCA).